Role of tumor markers before or during chemotherapy for digestive neuroendocrine carcinomas as an exploratory analysis of JCOG1213

Abstract The clinical utility of tumor markers such as neuron-specific enolase (NSE) and progastrin-releasing peptide (ProGRP) in digestive neuroendocrine carcinoma (NEC) remains unclear. This exploratory analysis aimed to evaluate whether pretreatment and changes of tumor marker levels can predict...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tomoyuki Satake, Chigusa Morizane, Nozomu Machida, Yoshitaka Honma, Takuji Okusaka, Narikazu Boku, Ken Kato, Gakuto Ogawa, Yusuke Sano, Hiroshi Imaoka, Satoshi Kobayashi, Takeshi Terashima, Masafumi Ikeda, Naohiro Okano, Kensei Yamaguchi, Takuji Sato, Nobumasa Mizuno, Yuko Kitagawa, Masanori Terashima, Makoto Ueno
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2026-04-01
Col·lecció:	Scientific Reports
Matèries:	Neuroendocrine carcinoma Tumor marker Neuron-specific enolase Progastrin-releasing peptide
Accés en línia:	https://doi.org/10.1038/s41598-026-48891-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!